logo
AAT Bioquest

Adenosine A2b receptor Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
N-(1,3-Benzodioxol-5-yl)-2-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxyacetamideIC5038.0 [1]
CaffeineKi20500.0 [1]
8-Cyclopentyl-1,3-dipropylxanthineIC503.8 [1]
8-Cyclopentyl-1,3-dipropylxanthineKi51.0 [1], 1000.0 [2]
4-{2-[(7-Amino-2-Furan-2-Yl[1,2,4]triazolo[1,5-A][1,3,5]triazin-5-Yl)amino]ethyl}phenolIC5048.0 [1], 51.0 [2], 94.9 [3]
4-{2-[(7-Amino-2-Furan-2-Yl[1,2,4]triazolo[1,5-A][1,3,5]triazin-5-Yl)amino]ethyl}phenolKi42.0 [1], 50.0 [2]
5'-N-EthylcarboxamidoadenosineKi760.0 [1]
9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imineIC5060.7 [1], 1200.0 [2]
9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imineKi44.0 [1]
Mcp-necaKi2056.0 [1], 2100.0 [2]
1-[4-(Furan-2-yl)-11-methyl-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-3-phenylureaKi222.0 [1]
1-[4-(Furan-2-yl)-11-methyl-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-3-pyridin-4-ylureaIC501000.0 [1]
1-[4-(Furan-2-yl)-11-methyl-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-3-pyridin-4-ylureaKi200.0 [1], 250.0 [2]
EnprofyllineKi4700.0 [1], 4730.0 [2], 6400.0 [3]
IstradefyllineKi1800.0 [1], 10000.0 [2]
N-[4-(Furan-2-yl)-11-(3-phenylpropyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-2-naphthalen-1-ylacetamideIC50110.0 [1], 100000.0 [2]
N-[4-(Furan-2-yl)-11-(3-phenylpropyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-2-naphthalen-1-ylacetamideKi20.0 [1]
8-(4-(4-Benzylpiperazin-1-ylsulfonyl)phenyl)-1-propyl-1H-purine-2,6(3H,7H)-dioneIC5010.1 [1]
8-(4-(4-Benzylpiperazin-1-ylsulfonyl)phenyl)-1-propyl-1H-purine-2,6(3H,7H)-dioneKi1.33 [1], 3.6 [2]
2-(3,4-Dimethoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]acetamideIC50120.0 [1]
2-(3,4-Dimethoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]acetamideKi38.0 [1]
2-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxy-N-(4-fluorophenyl)acetamideIC5088.0 [1]
2-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxy-N-(4-fluorophenyl)acetamideKi12.0 [1]
8-PhenyltheophyllineIC50210.0 [1], 415.0 [2]
8-PhenyltheophyllineKi415.0 [1]
CID 10046145Ki2900.0 [1], 10000.0 [2]
8-[4-[4-(4-Chlorophenyl)piperazin-1-yl]sulfonylphenyl]-1-propyl-3,7-dihydropurine-2,6-dioneIC500.74 [1], 1.13 [2], 18.3 [3]
8-[4-[4-(4-Chlorophenyl)piperazin-1-yl]sulfonylphenyl]-1-propyl-3,7-dihydropurine-2,6-dioneKi0.55 [1]
5-Methyl-2-phenylpyrazolo[4,3-d]pyrimidin-7-amineIC50320.0 [1]
2,5-Diphenylpyrazolo[4,3-d]pyrimidin-7-amineIC50440.0 [1]
5-Benzyl-2-phenylpyrazolo[4,3-d]pyrimidin-7-amineIC50420.0 [1]
N-(7-Acetamido-4-methoxy-1,3-benzothiazol-2-yl)-4-fluorobenzamideIC50350.0 [1]
N-(7-Acetamido-4-methoxy-1,3-benzothiazol-2-yl)-4-fluorobenzamideKi130.0 [1]
N-[7-[Acetyl(ethyl)amino]-4-methoxy-1,3-benzothiazol-2-yl]-2-methylpyrazole-3-carboxamideIC5021.0 [1]
N-[7-[Acetyl(ethyl)amino]-4-methoxy-1,3-benzothiazol-2-yl]-2-methylpyrazole-3-carboxamideKi8.0 [1]
N-[7-[Acetyl(ethyl)amino]-4-methoxy-1,3-benzothiazol-2-yl]-1-[[3-(trifluoromethyl)phenyl]methyl]pyrazole-4-carboxamideIC506.0 [1]
N-[7-[Acetyl(ethyl)amino]-4-methoxy-1,3-benzothiazol-2-yl]-1-[[3-(trifluoromethyl)phenyl]methyl]pyrazole-4-carboxamideKi4.0 [1]
8-(p-Sulfophenyl)theophyllineKi1330.0 [1]
2-(Furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amineKi1110.0 [1], 10000.0 [2]
3,7-Dimethyl-1-propargylxanthineKi4130.0 [1]
1,3-Dipropyl-8-p-sulfophenylxanthineKi250.0 [1]
PreladenantKi1000.0 [1], 1700.0 [2]
4-(Furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amineKi10000.0 [1]
4-(2,6-Dioxo-1-propyl-2,3,6,7-tetrahydro-1H-purin-8-yl)benzenesulfonic acidKi53.4 [1]
Cvt-6883Ki8.3 [1], 22.0 [2]
Sodium;4-(2,6-dioxo-1-propyl-3,7-dihydropurin-8-yl)benzenesulfonateKi53.4 [1], 237.0 [2]
TonapofyllineKi90.0 [1]
[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy]acetic acidKi39.81 [1], 40.0 [2]
1-[11-Ethyl-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-3-(4-methoxyphenyl)ureaKi245.0 [1]
1-[4-(Furan-2-yl)-11-methyl-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-3-(4-methoxyphenyl)ureaKi261.0 [1]
1-[11-Butyl-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-3-(4-methoxyphenyl)ureaKi303.0 [1]
CID 2748294Ki40.8 [1]
Ethyl 6-methyl-2-oxo-4-(thiophen-3-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylateKi23.6 [1]
Pyrimidine-5-carboxylic acid, 1,2,3,4-tetrahydro-4-(2-furyl)-6-methyl-2-oxo-, ethyl esterKi585.5 [1]
Ethyl 4-(furan-3-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylateKi39.6 [1]
Unii-168SF9F04EIC50321.0 [1]
Unii-168SF9F04EKi17.0 [1]
N-[2-[[2-Phenyl-6-[4-(3-phenylpropyl)piperazine-1-carbonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethyl]acetamideKi0.4 [1], 0.41 [2], 0.5 [3]
8-[1-[[5-(4-Chlorophenyl)-1,2,4-oxadiazol-3-yl]methyl]pyrazol-4-yl]-1-propyl-3,7-dihydropurine-2,6-dioneKi7.0 [1]
N-[4-(Furan-2-yl)-11-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-2-phenylacetamideIC50210.0 [1], 3000.0 [2]
N-[4-(Furan-2-yl)-11-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-2-phenylacetamideKi35.0 [1]
8-[1-[(3-Fluorophenyl)methyl]pyrazol-4-yl]-1,3-dipropyl-7H-purine-2,6-dioneKi14.0 [1]
2-(4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy)-N-(4-iodophenyl)acetamideKi2.13 [1], 2.14 [2]
8-[2-Methyl-5-[2-oxo-2-(4-phenylpiperazin-1-yl)ethoxy]pyrazol-3-yl]-1,3-bis(prop-2-enyl)-7H-purine-2,6-dioneIC5081.0 [1]
8-[2-Methyl-5-[2-oxo-2-(4-phenylpiperazin-1-yl)ethoxy]pyrazol-3-yl]-1,3-bis(prop-2-enyl)-7H-purine-2,6-dioneKi24.0 [1]
4-[[2-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxyacetyl]amino]benzoic acidIC50115.0 [1]
4-[[2-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxyacetyl]amino]benzoic acidKi36.0 [1]
8-[2-Methyl-5-[2-oxo-2-(4-phenylpiperazin-1-yl)ethoxy]pyrazol-3-yl]-1,3-dipropyl-7H-purine-2,6-dioneIC5065.0 [1]
8-[2-Methyl-5-[2-oxo-2-(4-phenylpiperazin-1-yl)ethoxy]pyrazol-3-yl]-1,3-dipropyl-7H-purine-2,6-dioneKi15.0 [1]
N-(1,3-Benzodioxol-5-yl)-2-[[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1,2-oxazol-3-yl]oxy]acetamideIC50140.0 [1]
N-(1,3-Benzodioxol-5-yl)-2-[[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1,2-oxazol-3-yl]oxy]acetamideKi47.0 [1]
N-(3,4-Dichlorophenyl)-2-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxyacetamideIC5060.0 [1]
N-(3,4-Dichlorophenyl)-2-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxyacetamideKi16.0 [1]
N-(3,4-Dimethylphenyl)-2-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxyacetamideIC5040.0 [1]
N-(3,4-Dimethylphenyl)-2-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxyacetamideKi10.0 [1]
Ethyl 4-[[2-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxyacetyl]amino]benzoateIC50120.0 [1]
Ethyl 4-[[2-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxyacetyl]amino]benzoateKi32.0 [1]
N-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]-2-(4-phenylmethoxyphenyl)acetamideIC50185.0 [1]
N-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]-2-(4-phenylmethoxyphenyl)acetamideKi56.0 [1]
Propan-2-yl 6-methyl-2-oxo-4-thiophen-3-yl-3,4-dihydro-1H-pyrimidine-5-carboxylateKi56.6 [1], 56.7 [2]
2-(6-Amino-8-bromo-9H-purin-9-yl)ethanolKi2800.0 [1]
Propan-2-yl 4-(furan-3-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylateKi1486.0 [1]
8-(1-(3-(Trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-1,3-dipropyl-1H-purine-2,6(3H,7H)-dioneKi14.0 [1]
8-Bromo-9-propyl-9H-purin-6-ylamineKi200.0 [1]
CID 16071896IC50120.0 [1]
CID 16071896Ki24.0 [1]
2-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)pyridin-2-yl]oxy-N-(4-iodophenyl)acetamideIC50477.0 [1]
2-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)pyridin-2-yl]oxy-N-(4-iodophenyl)acetamideKi108.0 [1]
N-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]-2-[4-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]acetamideIC5093.0 [1]
N-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]-2-[4-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]acetamideKi13.0 [1]
N-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]-2-(3-fluorophenyl)acetamideIC50160.0 [1]
N-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]-2-(3-fluorophenyl)acetamideKi50.0 [1]
N-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]-2-phenylacetamideIC50103.0 [1]
N-[5-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]-2-phenylacetamideKi35.0 [1]
2-(4-Chlorophenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]acetamideIC50128.0 [1]
2-(4-Chlorophenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]acetamideKi28.0 [1]
8-[2-Methyl-5-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]pyrazol-3-yl]-1,3-dipropyl-7H-purine-2,6-dioneIC50322.0 [1]
8-[2-Methyl-5-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]pyrazol-3-yl]-1,3-dipropyl-7H-purine-2,6-dioneKi76.0 [1], 122.0 [2]



References

This online tool may be cited as follows

MLA

"Quest Database™ Adenosine A2b receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Nov2024https://www.aatbio.com/data-sets/adenosine-a2b-receptor-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 20). Quest Database™ Adenosine A2b receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/adenosine-a2b-receptor-inhibitors-ic50-ki.
BibTeXEndNoteRefMan